NCT06048913 2025-07-04
Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Completed
Clinical Trials
18 trialsNCT05278728 2025-02-07
Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 1/2 Completed
NCT04207918 2024-05-16
A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Completed
NCT03025958 2024-05-06
Radiation Plus Concurrent Nimotuzumab in Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Phase 2 Completed
NCT06363084 2024-04-12
A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer
Ruijin Hospital
Completed
NCT02395016 2024-04-04
A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 3 Completed
NCT02947386 2023-10-05
Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer
Roswell Park Cancer Institute
Phase 1 Completed
NCT00702481 2023-02-28
Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell Cancer
National Cancer Centre, Singapore
Phase 2 Completed
NCT04475016 2022-06-09
TIP (Paclitaxel + Ifosfamide + Cisplatin) Combined With Nimotuzumab & Triprilimab as Neoadjuvant Treatment in Locally Advanced Penile Cancer
Sun Yat-sen University
Phase 2 Completed
NCT04508816 2022-04-04
Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy
Fudan University
Phase 2 Completed
NCT02591784 2022-03-17
Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT02577341 2021-02-11
Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer
Sun Yat-sen University
Phase 2 Completed
NCT03388372 2018-01-03
Nimotuzumab Plus Radiotherapy With Concomitant and Adjuvant Temozolomide for Cerebral Glioblastoma
Biotech Pharmaceutical Co., Ltd.
Phase 2 Completed
NCT01616849 2015-09-22
Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 2 Completed
NCT00950417 2015-08-19
Nimotuzumab in Combination With Chemoradiation for Esophageal Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 1 Completed
NCT01498562 2014-12-02
DATE
Yonsei University
Phase 2 Completed
NCT01425736 2014-06-03
Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Completed
NCT00910117 2012-02-20
Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
Fudan University
Phase 2 Completed